Female Libido Drug: Is It Safe and Effective

In August 2015, the U.S. Food and Drug Administration approved the medication flibanserin (Addyi) for use in premenopausal women with hypoactive sexual desire disorder (HSDD). But some researchers have questioned its efficacy and safety, claiming the side effects may not be worth it. Dr. Jordan Rullo is a member of the International Society for the Study of Women's Sexual Health (ISSWSH). She and her colleagues support the use of this drug for the subset of women who benefit from it.